Artemis Investment Management LLP
Position in COLL — Collegium Pharmaceutical, Inc
CIK 1535385
EDINBURGH, X0
Position in COLL
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,482,342
+$1,783,871 QoQ
Shares Held
68,573
+224.7% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#71
of 279 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Artemis Investment Management LLP holds $81,674,270 across 5 Drug Manufacturers - Specialty & Generic names. COLL ranks #3 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
2,966,646 | $73,009,158 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
186,125 | $3,221,823 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
This page
|
68,573 | $2,482,342 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
28,176 | $2,332,409 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
15,319 | $628,538 |
All Filings in COLL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,482,342 | 68,573 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $698,471 | 21,121 | Shares | Sole | 2026-04-13 | |
| No filing history on record for this holder in this stock. | ||||||